We are live on !
Find out more
Lindbrook Capital Portfolio holdings
AUM
$1.08B
Turnover
13.43%
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter Est. Return
-2.72%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
-$23.9M
(-2.2%)
Cap. Flow
+$21M
Cap. Flow % of AUM
Cap. Flow %
1.94%
Top 10 Holdings %
Top 10 Hldgs %
44.12%
Holding
2,978
New
204
Increased
1,436
Reduced
715
Closed
196
Avg Time Held
3.6
years
Top 10 Avg Time Held
4.1
years
Top 20 Avg Time Held
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$4.94M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$4.77M |
| 3 |
RPAR Risk Parity ETF
RPAR
|
+$2.57M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$2.42M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$1.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.11M |
| 2 |
Coinbase
COIN
|
+$2.99M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.34M |
| 4 |
Calamos Convertible Opportunities and Income Fund
CHI
|
+$2.29M |
| 5 |
PepsiCo
PEP
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.21% |
| 2 | Technology | 16.49% |
| 3 | Financials | 11.64% |
| 4 | Healthcare | 5.47% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1126
First Horizon
FHN
$11.1B
| $36.2K | ﹤0.01% |
1,862
+649
| +54% | +$13.4K |
2018 Q4
25 quarters
|
|
1127
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.67B
| $36.1K | ﹤0.01% |
350
| – | – |
2021 Q4
13 quarters
|
|
1128
Littelfuse
LFUS
$9.8B
| $36K | ﹤0.01% |
183
+105
| +135% | +$24K |
2020 Q2
19 quarters
|
|
1129
Eagle Point Income Company
EIC
$214M
| $35.9K | ﹤0.01% |
2,400
+400
| +20% | +$6.27K |
2021 Q2
15 quarters
|
|
1130
Global X Lithium & Battery Tech ETF
LIT
$1.06B
| $35.9K | ﹤0.01% |
924
| – | – |
2020 Q4
17 quarters
|
|
1131
LivaNova
LIVN
$5.03B
| $35.7K | ﹤0.01% |
908
+743
| +450% | +$33.3K |
2022 Q1
12 quarters
|
|
1132
Vontier
VNT
$5.8B
| $35.6K | ﹤0.01% |
1,085
+497
| +85% | +$18.1K |
2020 Q4
17 quarters
|
|
1133
Dow Inc
DOW
$23.9B
| $35.6K | ﹤0.01% |
1,020
-1,385
| -58% | -$53.2K |
2019 Q2
23 quarters
|
|
1134
CNA Financial
CNA
$13.1B
| $35.6K | ﹤0.01% |
701
+168
| +32% | +$8.19K |
2020 Q2
19 quarters
|
|
1135
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$38.9B
| $35.5K | ﹤0.01% |
695
| – | – |
2024 Q2
3 quarters
|
|
1136
First Trust Preferred Securities and Income ETF
FPE
$5.79B
| $35.2K | ﹤0.01% |
2,000
| – | – |
2022 Q4
9 quarters
|
|
1137
Pilgrim's Pride
PPC
$6.7B
| $34.9K | ﹤0.01% |
641
+186
| +41% | +$9.3K |
2020 Q1
20 quarters
|
|
1138
Qfin Holdings
QFIN
$646M
| $34.9K | ﹤0.01% |
777
+113
| +17% | +$4.68K |
2020 Q1
20 quarters
|
|
1139
Ball Corp
BALL
$17B
| $34.9K | ﹤0.01% |
670
-25
| -4% | -$1.31K |
2018 Q4
25 quarters
|
|
1140
TG Therapeutics
TGTX
$9.8B
| $34.1K | ﹤0.01% |
864
+37
| +4% | +$1.24K |
2020 Q2
19 quarters
|
|
1141
Pembina Pipeline
PBA
$29.3B
| $34.1K | ﹤0.01% |
851
+29
| +4% | +$1.09K |
2021 Q4
13 quarters
|
|
1142
Evolent Health
EVH
$554M
| $33.7K | ﹤0.01% |
3,558
+1,516
| +74% | +$15.3K |
2020 Q1
20 quarters
|
|
1143
Western Alliance Bancorporation
WAL
$8.04B
| $33.7K | ﹤0.01% |
438
-7
| -2% | -$588 |
2023 Q1
8 quarters
|
|
1144
Regal Rexnord
RRX
$11.7B
| $33.4K | ﹤0.01% |
293
+192
| +190% | +$26.7K |
2020 Q3
18 quarters
|
|
1145
Sensata Technologies
ST
$5.61B
| $33.3K | ﹤0.01% |
1,372
+1,311
| +2,149% | +$36.3K |
2020 Q4
17 quarters
|
|
1146
Moderna
MRNA
$90.4B
| $33.3K | ﹤0.01% |
1,174
+1
| +0.1% | +$35 |
2020 Q1
20 quarters
|
|
1147
Huntsman Corp
HUN
$1.67B
| $33K | ﹤0.01% |
2,090
+1,285
| +160% | +$21.8K |
2021 Q4
13 quarters
|
|
1148
Wendy's
WEN
$1.58B
| $32.9K | ﹤0.01% |
2,252
-296
| -12% | -$4.45K |
2018 Q4
25 quarters
|
|
1149
DELISTED
RAPT Therapeutics
RAPT
| $32.9K | ﹤0.01% |
+3,375
| New | +$33.2K |
2025 Q1
0 quarters
|
|
1150
Churchill Downs
CHDN
$6.84B
| $32.9K | ﹤0.01% |
296
+172
| +139% | +$20.6K |
2022 Q3
10 quarters
|
|
Similar funds
CIG
CCM
Lindbrook Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Lindbrook Capital held 2,978 positions worth $1.08B, down 2.2% from $1.11B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Lindbrook Capital's Q1 2025 filing shows 204 new, 1,436 increased, 715 reduced and 196 closed positions. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 14,620 shares worth $1.41M. The largest sale was iShares Core S&P 500 ETF, an estimated $5.11M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Lindbrook Capital's largest Q1 2025 buy was State Street Communication Services Select Sector SPDR ETF: 14,620 shares worth $1.41M.
- Lindbrook Capital added most to State Street Technology Select Sector SPDR ETF in Q1 2025, an estimated $4.94M increase.
- Lindbrook Capital's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.11M.
- Lindbrook Capital fully exited iShares Core US Aggregate Bond ETF in Q1 2025, selling an estimated $2.34M.
- Lindbrook Capital's ten largest holdings make up 44% of its $1.08B portfolio in Q1 2025.
- Lindbrook Capital opened 204 new positions and closed 196 in Q1 2025.
- Lindbrook Capital's portfolio value fell 2.2% quarter-over-quarter to $1.08B.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.